Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

11296	Companies
251050	Keywords
179984	Articles
136900	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 04/22/2026 at 06:30, 6 months 17 days ago

Formycon reports successful financial year 2025 with important operational progress, growing market presence and strategic partnerships
Formycon AG reports successful financial year 2025 with operational progress, market growth, and strategic partnerships. Forecast for 2026 includes revenue growth and positive EBITDA

Strategic Partnerships Formycon AG Operational Progress Market Presence Financial Year 2025
BRIEF

published on 04/20/2026 at 06:35, 6 months 19 days ago

Formycon Announces 2025 Financial Results Conference Call and 2026 Investor Conferences

Conference Call Formycon AG Management Board Financial Results 2025 Investor Conferences 2026
BRIEF

published on 04/20/2026 at 06:35, 6 months 19 days ago

Formycon annonce sa conférence téléphonique sur les résultats financiers de 2025 et ses conférences pour les investisseurs en 2026.

Conseil D'administration Formycon AG Conférence Téléphonique Résultats Financiers 2025 Conférences Pour Investisseurs 2026
PRESS RELEASE

published on 04/20/2026 at 06:30, 6 months 19 days ago

Formycon invites to Conference Call on the Results of the Financial Year 2025 and announces Participation in international Investor Conferences in the 2nd Quarter of 2026
Formycon AG to hold Conference Call on Results of FY 2025 and participate in international Investor Conferences in Q2 2026. Details and registration at provided links

Conference Call Investor Conferences Formycon AG Biosimilars Financial Year 2025
BRIEF

published on 04/15/2026 at 19:57, 6 months 23 days ago

Formycon AG annonce des résultats préliminaires améliorés pour l'exercice 2025.

Formycon AG Fonds De Roulement États Financiers Annuels Exercice Financier 2025 EBITDA Du Groupe
BRIEF

published on 04/15/2026 at 19:57, 6 months 23 days ago

Formycon AG Reports Improved Preliminary Figures for 2025 Fiscal Year

Working Capital Annual Financial Statements Formycon AG 2025 Fiscal Year Group EBITDA
PRESS RELEASE

published on 04/15/2026 at 19:52, 6 months 23 days ago

EQS-Adhoc: Formycon AG:
Formycon AG announces improved preliminary figures for the 2025 fiscal year, including adjusted EBITDA and working capital, with annual financial statements publication set for April 22, 2026

Financial Statements EBITDA Formycon AG Preliminary Figures 2025 Fiscal Year
BRIEF

published on 03/19/2026 at 06:35, 7 months 21 days ago

Formycon obtient l'autorisation de commercialiser un biosimilaire en Europe et au-delà.

Formycon Maladies De La Rétine Expansion Du Marché Licences De Biosimilaires Règlement De Brevet
BRIEF

published on 03/19/2026 at 06:35, 7 months 21 days ago

Formycon Secures Licensing for Biosimilar in Europe and Beyond

Market Expansion Formycon Retinal Diseases Biosimilar Licensing Patent Settlement
PRESS RELEASE

published on 03/19/2026 at 06:30, 7 months 21 days ago

Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer
Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer

Bayer Biosimilar Formycon Regeneron Aflibercept

Accesswire

Published on 11/09/2026 at 12:30, 9 minutes ago

Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
Published on 11/06/2026 at 22:15, 2 days 14 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 23 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 3 days ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 3 days ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 12:20, 19 minutes ago

Recommended Cash Offer for Irish Residential Properties REIT plc
Published on 11/09/2026 at 12:15, 24 minutes ago

Huawei Chronicles 30 Years of Wireless Innovation in a Documentary for the First Time
Published on 11/09/2026 at 11:05, 1 hour 34 minutes ago

Velvet, mirrors and rooms upstairs: inside Lisbon's Pensão Amor
Published on 11/09/2026 at 11:05, 1 hour 34 minutes ago

THE 50 BEST VINEYARDS REVEALS THE 51-100 LIST FOR 2026
Published on 11/09/2026 at 11:00, 1 hour 39 minutes ago

LINXAI Robotics Claims Gold and Two Bronzes at First CMG World Robot Mount Tai Competition

Les Echos

Published on 11/09/2026 at 10:32, 2 hours 7 minutes ago

Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 2 hours 7 minutes ago

Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 5 hours 39 minutes ago

bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 5 hours 39 minutes ago

BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 5 hours 39 minutes ago

Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine

View all LES ECHOS COMFI WIRE